Evidence map›Paper›PMID 37894368›Full record

ArticleCancers2023

International Variations in Surgical Morbidity and Mortality Post Gynaecological Oncology Surgery: A Global Gynaecological Oncology Surgical Outcomes Collaborative Led Study (GO SOAR1).

Faiza Gaba, Karen Ash, Oleg Blyuss, Nicolò Bizzarri, Paul Kamfwa, Allison Saiz, David Cibula, GO SOAR Collaborators

Registry-linked trialAbstract read
In one paragraph

Article in Cancers, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04579861 (Determining Post-operative Morbidity and Mortality Following Gynaecological Oncology Surgery), which is not on this map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04579861 unknown statusnot on this map

Determining Post-operative Morbidity and Mortality Following Gynaecological Oncology Surgery: a Multicentre, International, Prospective Cohort Study Led by the Global Gynaecological Oncology Surgical Outcomes Collaborative (GO SOAR)

TypeobservationalSponsorFaiza GabaRan2021 to 2023Enrolled1,100ConditionsGynecologic Cancer, Surgery, Surgery--ComplicationsArmsProspective data collection following gynaecological oncology surgery
3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Faiza GabaDepartment of Gynaecological Oncology, Royal London Hospital, Barts Health NHS Trust, London E1 1FR, UK.ORCID 0000-0003-4081-6883
Karen AshAberdeen Royal Infirmary, NHS Grampian, Aberdeen AB25 2ZN, UK.
Oleg BlyussWolfson Institute of Population Health, Queen Mary University of London, London EC1M 6BQ, UK.ORCID 0000-0002-0194-6389
Nicolò BizzarriUOC Ginecologia Oncologica, Dipartimento per la Salute della Donna e del Bambino e della Salute Pubblica, Fondazione Policlinico Universitario A. Gemelli, IRCCS, 00168 Rome, Italy.
Paul KamfwaCancer Diseases Hospital, Lusaka 10101, Zambia.
Allison SaizNorthwestern University in Chicago, Chicago, IL 60611, USA.
David CibulaDepartment of Obstetrics and Gynaecology, First Faculty of Medicine, Charles University and General University Hospital, 121 08 Prague, Czech Republic.ORCID 0000-0001-6387-9356
GO SOAR Collaborators

Funding

Grampian Endowment Fund ES882Medtronic A 1624702
6 · The paper itself

Abstract

Gynaecological malignancies affect women in low and middle income countries (LMICs) at disproportionately higher rates compared with high income countries (HICs) with little known about variations in access, quality, and outcomes in global cancer care. Our study aims to evaluate international variation in post-operative morbidity and mortality following gynaecological oncology surgery between HIC and LMIC settings. Study design consisted of a multicentre, international prospective cohort study of women undergoing surgery for gynaecological malignancies (NCT04579861). Multilevel logistic regression determined relationships within three-level nested-models of patients within hospitals/countries. We enrolled 1820 patients from 73 hospitals in 27 countries. Minor morbidity (Clavien-Dindo I-II) was 26.5% (178/672) and 26.5% (267/1009), whilst major morbidity (Clavien-Dindo III-V) was 8.2% (55/672) and 7% (71/1009) for LMICs/HICs, respectively. Higher minor morbidity was associated with pre-operative mechanical bowel preparation (OR = 1.474, 95%CI = 1.054-2.061,

Indexed as

collaborative researchgynaecological oncologymorbiditymortalitysurgery

Identifiers

PMID37894368
PMCPMC10605858

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.